FDA Adverse Event Malfunction Summary report: N

IMMULITE 2000 PROSTATE SPECIFIC ANTIGEN

MDR report key: 3201731 · Received July 2, 2013

Report

Report Number
2432235-2013-00261
Event Type
Malfunction
Date Received
July 2, 2013
Date of Event
March 18, 2013
Report Date
June 13, 2013
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS
Product Code
MTF
PMA / PMN Number
P930027
Removal / Correction Number
2432235-06/25/13-003-R
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
HU
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

SIEMENS HAS INVESTIGATED THE INCIDENCE OF POSITIVE BIAS ON IMMULITE 2000 PSA ASSAY, AND A POSITIVE BIAS OF (B)(4)PERCENT RELATIVE TO WHO (B)(4) HAS BEEN CONFIRMED. AN URGENT FIELD SAFETY NOTICE (UFSN) - (B)(4) IMMULITE/IMMULITE 2000/IMMULITE 2000 XPI PSA POSITIVE BIAS TO WHO (B)(4) - WAS SENT TO CUSTOMERS IN JUNE 2013. THE UFSN STATES THAT CUSTOMERS ARE TO DISCONTINUE USE OF THE PRODUCT AND DISCARD AFFECTED KITS REMAINING IN THEIR INVENTORY.

Additional Manufacturer Narrative · 1

THE INITIAL MDR 2432235-2013-00261 WAS FILED ON JULY 2, 2013 ADDITIONAL INFORMATION (07/03/2013): THE CAUSE OF THE POSITIVE BIAS ON THE IMMULITE 2000 PSA ASSAY IS A CONTROL SYSTEM DEFICIENCY.

Description of Event or Problem · 1

THE CUSTOMER HAS OBSERVED A HIGH BIAS FOR THE IMMULITE PROSTATE SPECIFIC ANTIGEN (PSA) ASSAY USING REAGENT LOT 382. THE ASSAY WAS RUN ON AN IMMULITE 2000 INSTRUMENT, AND THE HIGH BIAS AFFECTED BIORAD QUALITY CONTROLS AND TOTAL PSA THE RESULTS OBTAINED FROM REAGENT LOT 382 WERE SIMILAR TO RESULTS FROM REAGENT LOT 381 AS PER CUSTOMER. THE CUSTOMER DID NOT REPORT PROBLEMS WITH THE PATIENT RESULTS. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE HIGH BIAS ON THE PSA ASSAY WHEN USING REAGENT LOT 381.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
302405 IMMULITE 2000 PROSTATE SPECIFIC ANTIGEN IMMULITE 2000 PROSTATE SPECIFIC ANTIGEN MTF SIEMENS HEALTHCARE DIAGNOSTICS IMMULITE 2000 PROSTATE SPECIFIC ANTIGEN 382

Patients

Seq Age Sex Outcome Treatment
1